Martin Bopst

Martin Bopst has extensive experience in toxicology and project leadership, currently serving as Project Leader Toxicology and Head of Marketed/Established Products at F. Hoffmann-La Roche Ltd since February 2001. Prior to this role, Martin Bopst worked as a Toxicologist at UCB from January 1998 to January 2001, where responsibilities included serving as Project Toxicologist, Study Director, and Sponsor’s Study Monitor. Additionally, Martin Bopst was a Postdoctoral Fellow at ETH, Swiss Federal Institute of Technology in Zurich for a brief period in 1997, focusing on the mechanisms of gastrointestinal and liver toxicity of NSAIDs. Martin Bopst earned a Doctor of Philosophy (Ph.D.) in Immunology and Toxicology from ETH Zürich, completing this degree in 1997, and holds a Master's degree in Biology, specializing in Cell and Molecular Biology, from the University of Konstanz, obtained in 1992.